June 23, 2026

We are proud to see Cardiawave featured in Les Echos today, highlighting the deployment of the Valvosoft® technology and the next phase of development.
 
A big thank you to @Les Echos and to @Marion Simon-Rainaud for this insightful article and for showcasing Cardiawave’s mission to transform the treatment of aortic stenosis with a non-invasive approach to repair the valve instead of replacing it.🙏
 
This recognition comes at a key moment, as commercial deployment is starting in Europe and preparations are underway for future expansion in the United States. 🚀
 
At the same time, the @Capital Cell fundraising campaign — already oversubscribed — is entering its final days and will close on June 30.
 
👉 This is a unique opportunity to support a breakthrough technology aiming to help patients who have limited treatment options.
🔗 Discover and support the campaign: https://capitalcell.com/en/campaign/cardiawave/
🔗 Read the full Les Echos article here (subscribers only): https://www.lesechos.fr/start-up/impact/french-tech-apres-plus-de-dix-ans-de-rd-cardiawave-deploie-sa-valve-qui-repare-le-coeur-2238553
 
#MedTech #Cardiology #Innovation #StructuralHeart #AorticStenosis #Valvosoft #medtech #focusedultrasound #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #heartvalves #CEMarking
@AP‑HP, Assistance Publique – Hôpitaux de Paris #HEGP, @Physics for Medicine Paris, #InstitutLangevin, @CNRS, @ESPCI Paris – PSL, @Inserm @RHU_STOP_AS #FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @medtechinfrance @focusedultrasoundfoundation @eic-scalingclub @snitem